|
| Exchange Disseminated Time | Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2014, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 (Q2).
Further, as per the Company's Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees of the Company from October 21, 2014 to October 29, 2014 (both days inclusive). |
|
|